| Diagnosing destabilized heart failure in the emergency setting: current and future biomarker tests. | |
| | |
MedLine Citation:
|
PMID: 22188636 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Acute or destabilized heart failure (DHF) is characterized by new or worsening signs and symptoms of heart failure leading to admission to an emergency department. Biomarkers may support the diagnosis, the prognosis and the management of DHF patients. The aim of this review article is to discuss and evaluate the clinical usefulness of both recognized and potential new biomarker tests for use in heart failure. |
| | |
Authors:
|
Damien Gruson; Frédéric Thys; Franck Verschuren |
Related Documents
:
|
16105486 - Cardiac resynchronization therapy. 16598626 - Echocardiography-based optimization of cardiac resynchronization therapy in patients wi... 18715826 - Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients wi... 18445706 - Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. 3426896 - Chronic sinoatrial disorder (sick sinus syndrome): a possible result of cardiac ischaemia. 12960466 - Mri for the diagnosis of myocardial ischemia and viability. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Molecular diagnosis & therapy Volume: 15 ISSN: 1179-2000 ISO Abbreviation: Mol Diagn Ther Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-22 Completed Date: 2012-04-17 Revised Date: 2013-05-16 |
Medline Journal Info:
|
Nlm Unique ID: 101264260 Medline TA: Mol Diagn Ther Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 327-40 Citation Subset: IM |
Affiliation:
|
Pôle de Recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium. damien.gruson@uclouvain.be |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Biological Markers
/
metabolism* Emergencies Extracellular Matrix / metabolism Heart Failure / diagnosis*, metabolism Humans Inflammation / metabolism Myocytes, Cardiac / metabolism, pathology Neurotransmitter Agents / metabolism Oxidative Stress Prognosis |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Neurotransmitter Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.
Next Document: Musculature Tissue Engineering to Repair Abdominal Wall Hernia.